Trial Profile
Evaluation of a primary treatment algorithm using combination therapy for the management of patients with hypertension and hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary) ; ACE inhibitors; Alpha adrenergic receptor antagonists; Angiotensin receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Diuretics; Ezetimibe; Spironolactone
- Indications Hypercholesterolaemia; Hypertension
- Focus Therapeutic Use
- Acronyms STITCH2
- 13 Jun 2012 Additional lead trial centre (University of Western Ontario) identified as reported by ClinicalTrials.gov.
- 13 Jun 2012 Actual patient number is 1000 according to ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.